Pulmonx Corp Company Top Insiders
| LUNG Stock | USD 1.47 0.05 3.52% |
Roughly 88 percent of Pulmonx Corp's insiders are activelly selling. The analysis of insiders' sentiment of trading Pulmonx Corp stock suggests that a large number of insiders are panicking at this time. Pulmonx Corp employs about 291 people. The company is managed by 15 executives with a total tenure of roughly 679 years, averaging almost 45.0 years of service per executive, having 19.4 employees per reported executive.
Insider Sentiment 12
Mostly Selling
Selling | Buying |
Latest Trades
| 2025-12-01 | David Aaron Lehman | Disposed 10278 @ 1.57 | View | ||
| 2025-09-02 | Steven S Williamson | Disposed 9648 @ 1.6 | View | ||
| 2025-06-12 | Richard Ferrari | Disposed 8000 @ 3.16 | View | ||
| 2025-06-05 | Daniel P Florin | Acquired 23321 @ 3.06 | View | ||
| 2025-06-02 | Steven S Williamson | Disposed 9923 @ 3.13 | View | ||
| 2025-03-20 | Glendon E French III | Disposed 20000 @ 7.85 | View | ||
| 2025-03-03 | Steven S Williamson | Disposed 27689 @ 7.14 | View | ||
| 2025-02-20 | Glendon E French III | Disposed 55453 @ 8.28 | View |
Monitoring Pulmonx Corp's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. Pulmonx Corp Management Team Effectiveness
The company has return on total asset (ROA) of (0.2338) % which means that it has lost $0.2338 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7373) %, meaning that it created substantial loss on money invested by shareholders. Pulmonx Corp's management efficiency ratios could be used to measure how well Pulmonx Corp manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.33. The current Return On Capital Employed is estimated to decrease to -0.39. At this time, Pulmonx Corp's Net Tangible Assets are most likely to increase significantly in the upcoming years. The Pulmonx Corp's current Other Current Assets is estimated to increase to about 4.9 M, while Total Assets are projected to decrease to roughly 101.3 M.The current Common Stock Shares Outstanding is estimated to decrease to about 38.1 M. The Pulmonx Corp's current Net Loss is estimated to increase to about (50.4 M)Pulmonx Corp owns a total of 41.25 Million outstanding shares. The majority of Pulmonx Corp outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Pulmonx Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Pulmonx Corp. Please pay attention to any change in the institutional holdings of Pulmonx Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 2019-03-31 | Previous Quarter 40.2 M | Current Value 40.9 M | Avarage Shares Outstanding 32.8 M | Quarterly Volatility 10.6 M |
Pulmonx Corp Workforce Comparison
Pulmonx Corp is rated second overall in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 1,459. Pulmonx Corp retains roughly 291 in number of employees claiming about 20% of equities under Health Care industry.
Pulmonx Corp Profit Margins
The company has Profit Margin (PM) of (0.62) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.67) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.67.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.56 | 0.67 |
|
|
Pulmonx Corp Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pulmonx Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pulmonx Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Pulmonx Corp insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sri Radhakrishnan over three weeks ago Insider Trading | ||
Florin Daniel P over two months ago Disposition of 23321 shares by Florin Daniel P of Pulmonx Corp at 1.99 subject to Rule 16b-3 | ||
David Lehman over two months ago Disposition of 3401 shares by David Lehman of Pulmonx Corp at 1.57 subject to Rule 16b-3 | ||
Glendon French over three months ago Acquisition by Glendon French of 37153 shares of Pulmonx Corp subject to Rule 16b-3 | ||
David Lehman over three months ago Disposition of 535 shares by David Lehman of Pulmonx Corp at 3.14 subject to Rule 16b-3 | ||
Ferrari Richard over six months ago Disposition of 8000 shares by Ferrari Richard of Pulmonx Corp at 3.16 subject to Rule 16b-3 | ||
Geoffrey Rose over six months ago Disposition of 1724 shares by Geoffrey Rose of Pulmonx Corp at 6.97 subject to Rule 16b-3 | ||
Glendon French over six months ago Disposition of 20000 shares by Glendon French of Pulmonx Corp at 6.52 subject to Rule 16b-3 |
Pulmonx Corp Notable Stakeholders
A Pulmonx Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pulmonx Corp often face trade-offs trying to please all of them. Pulmonx Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pulmonx Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Steven Williamson | President CEO | Profile | |
| Glendon French | President CEO | Profile | |
| David Lehman | General Secretary | Profile | |
| Geoffrey Rose | Chief Officer | Profile | |
| Lauren Cristina | Vice Administration | Profile | |
| John McKune | VP Controller | Profile | |
| Sri Radhakrishnan | Chief Officer | Profile | |
| Mehul Joshi | Chief Officer | Profile | |
| Jrme Erath | Senior International | Profile | |
| Marcee Maroney | Vice Marketing | Profile | |
| Narinder Shargill | Senior Affairs | Profile | |
| Derrick Sung | Chief Officer | Profile | |
| Sarah Huber | Vice Sales | Profile | |
| Lisa Paul | Chief Officer | Profile | |
| David JD | General Secretary | Profile |
About Pulmonx Corp Management Performance
The success or failure of an entity such as Pulmonx Corp often depends on how effective the management is. Pulmonx Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pulmonx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pulmonx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.32) | (0.33) | |
| Return On Capital Employed | (0.38) | (0.39) | |
| Return On Assets | (0.31) | (0.33) | |
| Return On Equity | (0.76) | (0.72) |
Pulmonx Corp Workforce Analysis
Traditionally, organizations such as Pulmonx Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pulmonx Corp within its industry.Pulmonx Corp Manpower Efficiency
Return on Pulmonx Corp Manpower
| Revenue Per Employee | 287.9K | |
| Revenue Per Executive | 5.6M | |
| Net Loss Per Employee | 193.8K | |
| Net Loss Per Executive | 3.8M | |
| Working Capital Per Employee | 384.2K | |
| Working Capital Per Executive | 7.5M |
Complementary Tools for Pulmonx Stock analysis
When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |